000 | 01226 a2200313 4500 | ||
---|---|---|---|
005 | 20250518055844.0 | ||
264 | 0 | _c20190912 | |
008 | 201909s 0 0 eng d | ||
022 | _a0080-0015 | ||
024 | 7 |
_a10.1007/978-3-030-23765-3_6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPaschen, Annette | |
245 | 0 | 0 |
_aThe Era of Checkpoint Inhibition: Lessons Learned from Melanoma. _h[electronic resource] |
260 |
_bRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer _c2020 |
||
300 |
_a169-187 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAntibodies, Monoclonal |
650 | 0 | 4 | _aB7-H1 Antigen |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _xcytology |
650 | 0 | 4 | _aEurope |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aMelanoma _xtherapy |
650 | 0 | 4 | _aProgrammed Cell Death 1 Receptor |
650 | 0 | 4 | _aTumor Microenvironment |
700 | 1 | _aSchadendorf, Dirk | |
773 | 0 |
_tRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer _gvol. 214 _gp. 169-187 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-030-23765-3_6 _zAvailable from publisher's website |
999 |
_c30065660 _d30065660 |